A citation-based method for searching scientific literature

Alexander R Moschen, Herbert Tilg, Tim Raine. Nat Rev Gastroenterol Hepatol 2019
Times Cited: 160







List of co-cited articles
656 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Brian G Feagan, William J Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R Friedman, Marion A Blank, Jewel Johanns, Long-Long Gao, Ye Miao,[...]. N Engl J Med 2016
838
19

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.
Wolfgang Hueber, Bruce E Sands, Steve Lewitzky, Marc Vandemeulebroecke, Walter Reinisch, Peter D R Higgins, Jan Wehkamp, Brian G Feagan, Michael D Yao, Marek Karczewski,[...]. Gut 2012
953
17

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Bruce E Sands, William J Sandborn, Remo Panaccione, Christopher D O'Brien, Hongyan Zhang, Jewel Johanns, Omoniyi J Adedokun, Katherine Li, Laurent Peyrin-Biroulet, Gert Van Assche,[...]. N Engl J Med 2019
352
16

Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study.
Bruce E Sands, Jingjing Chen, Brian G Feagan, Mark Penney, William A Rees, Silvio Danese, Peter D R Higgins, Paul Newbold, Raffaella Faggioni, Kaushik Patra,[...]. Gastroenterology 2017
155
12

Increased expression of interleukin 17 in inflammatory bowel disease.
S Fujino, A Andoh, S Bamba, A Ogawa, K Hata, Y Araki, T Bamba, Y Fujiyama. Gut 2003
11

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.
Richard H Duerr, Kent D Taylor, Steven R Brant, John D Rioux, Mark S Silverberg, Mark J Daly, A Hillary Steinhart, Clara Abraham, Miguel Regueiro, Anne Griffiths,[...]. Science 2006
11

Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
William J Sandborn, Christopher Gasink, Long-Long Gao, Marion A Blank, Jewel Johanns, Cynthia Guzzo, Bruce E Sands, Stephen B Hanauer, Stephan Targan, Paul Rutgeerts,[...]. N Engl J Med 2012
735
11

Cytokines in inflammatory bowel disease.
Markus F Neurath. Nat Rev Immunol 2014
10

IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.
David Yen, Jeanne Cheung, Heleen Scheerens, Frédérique Poulet, Terrill McClanahan, Brent McKenzie, Melanie A Kleinschek, Alex Owyang, Jeanine Mattson, Wendy Blumenschein,[...]. J Clin Invest 2006
10

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study.
Brian G Feagan, William J Sandborn, Geert D'Haens, Julián Panés, Arthur Kaser, Marc Ferrante, Edouard Louis, Denis Franchimont, Olivier Dewit, Ursula Seidler,[...]. Lancet 2017
254
10

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
William J Sandborn, Chinyu Su, Bruce E Sands, Geert R D'Haens, Séverine Vermeire, Stefan Schreiber, Silvio Danese, Brian G Feagan, Walter Reinisch, Wojciech Niezychowski,[...]. N Engl J Med 2017
671
10

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
Siew C Ng, Hai Yun Shi, Nima Hamidi, Fox E Underwood, Whitney Tang, Eric I Benchimol, Remo Panaccione, Subrata Ghosh, Justin C Y Wu, Francis K L Chan,[...]. Lancet 2017
9

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.
Michele W L Teng, Edward P Bowman, Joshua J McElwee, Mark J Smyth, Jean-Laurent Casanova, Andrea M Cooper, Daniel J Cua. Nat Med 2015
451
9

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease.
Stephan R Targan, Brian Feagan, Severine Vermeire, Remo Panaccione, Gil Y Melmed, Carol Landers, Dalin Li, Chris Russell, Richard Newmark, Nan Zhang,[...]. Am J Gastroenterol 2016
204
9

IL-23 in inflammatory bowel diseases and colon cancer.
Markus F Neurath. Cytokine Growth Factor Rev 2019
72
12

Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease.
Matthias Friedrich, Mathilde Pohin, Fiona Powrie. Immunity 2019
202
8

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.
William J Sandborn, Marc Ferrante, Bal R Bhandari, Elina Berliba, Brian G Feagan, Toshifumi Hibi, Jay L Tuttle, Paul Klekotka, Stuart Friedrich, Michael Durante,[...]. Gastroenterology 2020
60
13

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.
Sofia Buonocore, Philip P Ahern, Holm H Uhlig, Ivaylo I Ivanov, Dan R Littman, Kevin J Maloy, Fiona Powrie. Nature 2010
813
8

A protective function for interleukin 17A in T cell-mediated intestinal inflammation.
William O'Connor, Masahito Kamanaka, Carmen J Booth, Terrence Town, Susumu Nakae, Yoichiro Iwakura, Jay K Kolls, Richard A Flavell. Nat Immunol 2009
583
8

Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study.
Brian G Feagan, Julián Panés, Marc Ferrante, Arthur Kaser, Geert R D'Haens, William J Sandborn, Edouard Louis, Markus F Neurath, Denis Franchimont, Olivier Dewit,[...]. Lancet Gastroenterol Hepatol 2018
88
9

Secukinumab in plaque psoriasis--results of two phase 3 trials.
Richard G Langley, Boni E Elewski, Mark Lebwohl, Kristian Reich, Christopher E M Griffiths, Kim Papp, Lluís Puig, Hidemi Nakagawa, Lynda Spelman, Bárður Sigurgeirsson,[...]. N Engl J Med 2014
7

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.
William J Sandborn, Brian G Feagan, Richard N Fedorak, Ellen Scherl, Mark R Fleisher, Seymour Katz, Jewel Johanns, Marion Blank, Paul Rutgeerts. Gastroenterology 2008
553
7

Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.
Aonghus Lavelle, Harry Sokol. Nat Rev Gastroenterol Hepatol 2020
331
7

Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability.
Jacob S Lee, Cristina M Tato, Barbara Joyce-Shaikh, Muhammet F Gulen, Corinne Cayatte, Yi Chen, Wendy M Blumenschein, Michael Judo, Gulesi Ayanoglu, Terrill K McClanahan,[...]. Immunity 2015
395
7

Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis.
Christopher S Smillie, Moshe Biton, Jose Ordovas-Montanes, Keri M Sullivan, Grace Burgin, Daniel B Graham, Rebecca H Herbst, Noga Rogel, Michal Slyper, Julia Waldman,[...]. Cell 2019
323
7

Anti-interleukin-12 antibody for active Crohn's disease.
Peter J Mannon, Ivan J Fuss, Lloyd Mayer, Charles O Elson, William J Sandborn, Daniel Present, Ben Dolin, Nancy Goodman, Catherine Groden, Ronald L Hornung,[...]. N Engl J Med 2004
628
7

Antibodies to interleukin 12 abrogate established experimental colitis in mice.
M F Neurath, I Fuss, B L Kelsall, E Stüber, W Strober. J Exp Med 1995
6


Innate Lymphoid Cells: 10 Years On.
Eric Vivier, David Artis, Marco Colonna, Andreas Diefenbach, James P Di Santo, Gérard Eberl, Shigeo Koyasu, Richard M Locksley, Andrew N J McKenzie, Reina E Mebius,[...]. Cell 2018
859
6

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.
B Oppmann, R Lesley, B Blom, J C Timans, Y Xu, B Hunte, F Vega, N Yu, J Wang, K Singh,[...]. Immunity 2000
6

Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology.
Holm H Uhlig, Brent S McKenzie, Sophie Hue, Claire Thompson, Barbara Joyce-Shaikh, Renata Stepankova, Nicolas Robinson, Sofia Buonocore, Helena Tlaskalova-Hogenova, Daniel J Cua,[...]. Immunity 2006
499
6

Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease.
Seung Won Kim, Eun Soo Kim, Chang Mo Moon, Jae Jun Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon. Gut 2011
98
6

Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.
Heike Schmitt, Ulrike Billmeier, Walburga Dieterich, Timo Rath, Sophia Sonnewald, Stephen Reid, Simon Hirschmann, Kai Hildner, Maximilian J Waldner, Jonas Mudter,[...]. Gut 2019
79
7

Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice.
Atsuhiro Ogawa, Akira Andoh, Yoshio Araki, Tadao Bamba, Yoshihide Fujiyama. Clin Immunol 2004
354
6

Infliximab for induction and maintenance therapy for ulcerative colitis.
Paul Rutgeerts, William J Sandborn, Brian G Feagan, Walter Reinisch, Allan Olson, Jewel Johanns, Suzanne Travers, Daniel Rachmilewitz, Stephen B Hanauer, Gary R Lichtenstein,[...]. N Engl J Med 2005
6

Vedolizumab as induction and maintenance therapy for ulcerative colitis.
Brian G Feagan, Paul Rutgeerts, Bruce E Sands, Stephen Hanauer, Jean-Frédéric Colombel, William J Sandborn, Gert Van Assche, Jeffrey Axler, Hyo-Jong Kim, Silvio Danese,[...]. N Engl J Med 2013
6

Induction of intestinal Th17 cells by segmented filamentous bacteria.
Ivaylo I Ivanov, Koji Atarashi, Nicolas Manel, Eoin L Brodie, Tatsuichiro Shima, Ulas Karaoz, Dongguang Wei, Katherine C Goldfarb, Clark A Santee, Susan V Lynch,[...]. Cell 2009
5

Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation.
Joseph R Maxwell, Yu Zhang, William A Brown, Carole L Smith, Fergus R Byrne, Mike Fiorino, Erin Stevens, Jeannette Bigler, John A Davis, James B Rottman,[...]. Immunity 2015
204
5

The global burden of IBD: from 2015 to 2025.
Gilaad G Kaplan. Nat Rev Gastroenterol Hepatol 2015
949
5

Epidemiology and risk factors for IBD.
Ashwin N Ananthakrishnan. Nat Rev Gastroenterol Hepatol 2015
757
5


Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease.
Wenyu Jiang, Jiewen Su, Xiaofei Zhang, Xiuqin Cheng, Jun Zhou, Ruihua Shi, Hongjie Zhang. Inflamm Res 2014
97
5

Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.
Jochem H Bernink, Lisette Krabbendam, Kristine Germar, Esther de Jong, Konrad Gronke, Michael Kofoed-Nielsen, J Marius Munneke, Mette D Hazenberg, Julien Villaudy, Christianne J Buskens,[...]. Immunity 2015
398
5

IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.
Marika C Kullberg, Dragana Jankovic, Carl G Feng, Sophie Hue, Peter L Gorelick, Brent S McKenzie, Daniel J Cua, Fiona Powrie, Allen W Cheever, Kevin J Maloy,[...]. J Exp Med 2006
435
5

JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.
Azucena Salas, Cristian Hernandez-Rocha, Marjolijn Duijvestein, William Faubion, Dermot McGovern, Severine Vermeire, Stefania Vetrano, Niels Vande Casteele. Nat Rev Gastroenterol Hepatol 2020
134
5

Immunological pathogenesis of inflammatory bowel disease.
Seung Hoon Lee, Jeong Eun Kwon, Mi-La Cho. Intest Res 2018
177
5

Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.
Tetsuro Takayama, Nobuhiko Kamada, Hiroshi Chinen, Susumu Okamoto, Mina T Kitazume, Jonathan Chang, Yumi Matuzaki, Sadafumi Suzuki, Akira Sugita, Kazutaka Koganei,[...]. Gastroenterology 2010
171
5

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease.
Alessandra Geremia, Carolina V Arancibia-Cárcamo, Myles P P Fleming, Nigel Rust, Baljit Singh, Neil J Mortensen, Simon P L Travis, Fiona Powrie. J Exp Med 2011
462
5

Crohn's disease.
Joana Torres, Saurabh Mehandru, Jean-Frédéric Colombel, Laurent Peyrin-Biroulet. Lancet 2017
813
5

Ulcerative colitis.
Ryan Ungaro, Saurabh Mehandru, Patrick B Allen, Laurent Peyrin-Biroulet, Jean-Frédéric Colombel. Lancet 2017
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.